August 2014 FDA Recall Warfarin Sodium by Taro Pharmaceuticals U.s.a., Inc.
D-1584-2014 - Failed Content Uniformity Specifications.

This Class III drug recall was voluntarily initiated by Taro Pharmaceuticals U.s.a., Inc. on August 25, 2014 for the product Warfarin Sodium. The FDA reported the reason for recall as failed content uniformity specifications.. The product was distributed in United States including: OH, HI, NH, MS, IL, TX, CA. and the recall is currently terminated.

Recall Number: D-1584-2014

Reason for Recall
Failed Content Uniformity Specifications.
Initiated
08-25-2014
Reported
09-24-2014
Quantity
1396 Bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Taro Pharmaceuticals U.S.A., Inc.
United States including: OH, HI, NH, MS, IL, TX, CA.
Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.

Batch or Lot Expiration Information

Lot# : 149400, Expiry: January 2016
Lot# : 149649, Expiry: January 2016.